I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Case report: Ruxolitinib as first-line therapy for secondar..:
Liu, Xiang
;
Zhu, Xueling
;
Zhou, Xiaotang
...
Frontiers in Immunology. 13 (2022) - p. , 2022
Link:
https://doi.org/10.3389/fimmu.2022.1012643
RT Journal T1
Case report: Ruxolitinib as first-line therapy for secondary hemophagocytic lymphohistiocytosis in patients with AIDS
UL https://suche.suub.uni-bremen.de/peid=cr-10.3389_fimmu.2022.1012643&Exemplar=1&LAN=DE A1 Liu, Xiang A1 Zhu, Xueling A1 Zhou, Xiaotang A1 Xie, Yirui A1 Xiang, Dairong A1 Wan, Zhikai A1 Huang, Ying A1 Zhu, Biao PB Frontiers Media SA YR 2022 SN 1664-3224 JF Frontiers in Immunology VO 13 LK http://dx.doi.org/https://doi.org/10.3389/fimmu.2022.1012643 DO https://doi.org/10.3389/fimmu.2022.1012643 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)